These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25720823)

  • 21. Nitric oxide synthesis blockade increases hypertrophy and cardiac fibrosis in rats submitted to aerobic training.
    Souza HC; Penteado DM; Martin-Pinge MC; Barbosa Neto O; Teixeira Vde P; Blanco JH; Silva VJ
    Arq Bras Cardiol; 2007 Aug; 89(2):88-93, 99-104. PubMed ID: 17874014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
    Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase.
    Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Liao Y; Ogai A; Kim J; Hori M; Kitakaze M
    J Am Coll Cardiol; 2002 Sep; 40(5):991-7. PubMed ID: 12225728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.
    Bell D; Zhao YY; Kelso EJ; McHenry EM; Rush LM; Lamont VM; Nicholls DP; McDermott BJ
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H904-14. PubMed ID: 16040721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
    Khattab MM; Mostafa A; Al-Shabanah O
    Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.
    Belge C; Hammond J; Dubois-Deruy E; Manoury B; Hamelet J; Beauloye C; Markl A; Pouleur AC; Bertrand L; Esfahani H; Jnaoui K; Götz KR; Nikolaev VO; Vanderper A; Herijgers P; Lobysheva I; Iaccarino G; Hilfiker-Kleiner D; Tavernier G; Langin D; Dessy C; Balligand JL
    Circulation; 2014 Jan; 129(4):451-62. PubMed ID: 24190960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
    Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE
    Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.
    Rhaleb NE; Yang XP; Scicli AG; Carretero OA
    Hypertension; 1994 Jun; 23(6 Pt 2):865-8. PubMed ID: 7515854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.
    Deng J; Wang YW; Chen WM; Wu Q; Huang XN
    Biol Pharm Bull; 2010; 33(4):631-5. PubMed ID: 20410597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice.
    Wunderlich C; Schmeisser A; Heerwagen C; Ebner B; Schober K; Braun-Dullaeus RC; Schwencke C; Kasper M; Morawietz H; Strasser RH
    Pulm Pharmacol Ther; 2008; 21(3):507-15. PubMed ID: 18226570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
    Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil.
    Nagayama T; Zhang M; Hsu S; Takimoto E; Kass DA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):380-7. PubMed ID: 18456872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
    Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
    Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O
    Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
    Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
    J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of inhaled NG-nitro-L-arginine methyl ester on Candida-induced acute lung injury.
    Nagata K; Iwasaki Y; Takemura Y; Harada H; Yokomura I; Fushiki S; Nakagawa M
    Chest; 2003 Dec; 124(6):2293-301. PubMed ID: 14665513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
    Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.